Kyoto University
Kyoto University is a Japanese national research university conducting advanced research in iPS cell regenerative medicine, AI, photonics, and space technologies, serving students, medical patients, and industry partners through education, hospital services, and technology licensing.
- Company typePublic
- Founded1897
- HeadquartersKyoto, Japan
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingServices
What Kyoto University does
Kyoto University (京都大学, Kyōto daigaku) is a Japanese national research university founded in 1897 and reorganized as a National University Corporation (国立大学法人) in 2004 under the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The university operates from its main Yoshida Campus in Sakyo-ku, Kyoto, with additional research campuses at Uji and Katsura, and serves a global population of domestic and international students, medical patients, industry partners, and the general public through education, advanced healthcare, and research collaboration. Its core technology and research portfolio spans induced pluripotent stem (iPS) cell regenerative medicine pioneered by Nobel laureate Shinya Yamanaka; transformer-based AI for biology (MaxToki); generative AI and embodied robotics (BuddhaBot, Buddharoid); 2µm-band photonic crystal surface-emitting lasers with Asahi Kasei; ytterbium atomic clocks for fundamental physics; and space technologies including self-healing CMOS imagers and the LignoSat wooden satellite project with NASA and JAXA.
The university's revenue model is non-commercial and institutionally diversified: it receives Japanese government operational subsidies (MEXT), competitive research grants (JST, NICT, JSPS, NWO, RAi UK), regulated tuition, and hospital service fees at Kyoto University Hospital (consultations ¥5,390–¥49,500; advanced procedures ¥605,000–¥1,587,080). Technology transfer and industry partnerships — notably with Mitsubishi Heavy Industries, Asahi Kasei Microdevices, Sharp, Sumitomo Pharma, Cuorips, and NVIDIA — provide co-development funding and licensing upside. In March 2026, the university became the first in the world to receive regulatory approval for iPS cell-derived therapeutic products for Parkinson's disease and heart failure, and in December 2025 it was selected as a candidate for Designated International Research University status, positioning it for accelerated funding and global standing.
Kyoto University firmographics
Firmographics- Name
- Kyoto University
- Legal name
- National University Corporation Kyoto University (国立大学法人京都大学)
- Website
- https://kyoto-u.ac.jp
- Company type
- Public
- Founded year
- 1897
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Kyoto University is a Japanese national research university conducting advanced research in iPS cell regenerative medicine, AI, photonics, and space technologies, serving students, medical patients, and industry partners through education, hospital services, and technology licensing.
- Ownership category
- akta.pro rank
Where Kyoto University is headquartered
LocationHeadquarters
- HQ city
- Kyoto
- HQ country
- Japan
- HQ region
- Asia
Offices4 records
Markets served
Kyoto University business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Medical treatment fees at Kyoto University Hospital are regulated by national health insurance and the university's fee schedule |
Distribution channels5 records
Marketing channels6 records
Kyoto University product offering
Product offeringCore offering
Kyoto University is a National University Corporation that delivers higher education (undergraduate through doctoral), advanced research outputs, and clinical care. Core offerings include degree programs across multiple faculties, industry-sponsored joint research, technology licensing, regenerative medicine products derived from iPS cell technology, AI models (MaxToki, BuddhaBot), photonic devices (PCSEL laser), hospital medical services, and continuing/public education.
Product overview
Kyoto University is a leading Japanese national research university that develops various AI systems, robotics, medical technologies, and scientific instruments. Key products include BuddhaBot, a generative AI chatbot for Buddhist scriptures, and Buddharoid, an AI-powered humanoid robot monk. The university also develops pharmaceutical products like TRG-035 tooth regrowth drug, medical diagnostic tools, scientific instruments including ytterbium atomic clocks, and collaborates on laser technologies with industry partners. These products span AI dialogue systems, robotics, regenerative medicine, diagnostic kits, and fundamental physics research instruments, with many still in research or clinical trial phases rather than commercial availability.
Differentiator
Problem solved
Functional benefit
Products and services
- BuddhaBot Generative AI chatbot trained on Buddhist scriptures, developed by Kyoto University researchers in collaboration with Teraverse and XNOVA, providing Buddhist spiritual guidance and text-based dialogue for temple visitors and spiritual seekers.
- Buddharoid AI-powered humanoid robot monk built on Unitree's G1 platform, powered by BuddhaBot-Plus AI, capable of walking, gesturing, performing prayer postures, and providing face-to-face spiritual guidance at Buddhist temples to address Japan's shortage of Buddhist monks.
- TRG-035 Tooth Regrowth Drug Pharmaceutical product that inhibits the USAG-1 protein to enable biological tooth regeneration by reactivating dormant tooth buds; currently in Phase 1 clinical trials at Kyoto University Hospital with 30 individuals aged 30-64 with missing teeth, targeting commercial release by 2030.
- MaxToki AI Model Transformer-based AI model developed by researchers from Gladstone Institutes, UCSF, UC Berkeley, NVIDIA, Goethe University Frankfurt, and Kyoto University to predict cellular aging trajectories across the human lifespan from single-cell transcriptomics data, achieving 87 months median prediction error.
- 2µm Band Infrared PCSEL Laser Next-generation photonic crystal surface-emitting laser co-developed with Asahi Kasei Microdevices for high-sensitivity greenhouse gas detection (CO2, CH4), non-invasive medical sensing, biomolecule sensing, breath gas analysis, and high-performance LiDAR applications.
- Ytterbium Atomic Clock Highly precise ytterbium-based atomic clock developed at Kyoto University's Graduate School of Science using 'magic wavelength' technique with 3D optical lattice, achieving 80 Hz spectral linewidth representing two-orders-of-magnitude improvement for testing the Standard Model and searching for dark matter.
- AI Long-Range Video Monitoring Technology Long-range video monitoring technology developed with Sharp Corporation using AI to analyze and record video from 5 to 10 km away, combining VHF band wireless transmission with Dynamic Video Monitoring Technology for animal behavior monitoring, ship video streaming, and disaster response applications.
- Noninvasive Diabetes Assessment Method Noninvasive diagnostic method developed at Kyoto University to assess diabetes, including early genetic signals linking diabetes subgroups to heart disease risk.
- Ulcerative Colitis Diagnostic Kit Diagnostic kit and targeted therapies under development at Kyoto University for ulcerative colitis, based on discovery of autoantibodies against a specific protein present in most patients.
- Self-Healing CMOS Imager Radiation-tolerant imaging sensor developed with Southern University of Science and Technology that detects and repairs radiation-damaged pixels individually through targeted heating, recovering functionality after radiation exposure for space applications.
- Kyoto University Hospital Medical Services Comprehensive medical services including advanced treatments, clinical trials, and specialized healthcare covering consultation fees, advanced medical procedures such as robot-assisted surgery (¥605,000-¥1,587,080), cancer gene panel tests (¥124,080-¥591,910), and dental implants (¥165,000-¥550,000 per procedure), with fees regulated by national health insurance.
- Academic Degree Programs Undergraduate, graduate, and professional degree programs serving domestic and international students through faculty admissions processes, including specialized research programs across multiple faculties.
- Open Courses and Public Education Public lectures, junior campus programs for middle school students, continuing education courses, and community engagement programs including temple-based programs and regional lecture series.
- Technology Licensing and Industry Partnership Services Technology transfer services through Industry-Academia-Government collaboration office, including licensing of university-developed technologies and joint research arrangements with corporate partners.
- iPS Cell-Derived Regenerative Medicine Products Therapeutic products derived from iPS cell technology including Amchepry (Parkinson's disease treatment) developed with Sumitomo Pharma and ReHeart (heart muscle sheets) developed with Cuorips, both receiving conditional regulatory approval in Japan as the world's first iPS cell-derived therapeutics.
Quantifiable outcome
- World's first regulatory approval for iPS cell-derived therapeutic products for heart disease
- +3 more outcomes
Companies that use Kyoto University
Customer profileSegments4 records
Ideal customer profiles4 records
Kyoto University technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability14 records
Feature9 records
Kyoto University partnerships and signals
Strategic signalPartnerships
31 partnerships are on record, tiered major, core and minor.
- Netherlands Organisation for Scientific Research (NWO)majorJoint funding for unconventional information processing technologies research under NWO-JST call. Five Dutch-Japanese research teams funded targeting alternatives to conventional computer chips including quantum, neuromorphic, and photonics computing.
- Japan Science and Technology Agency (JST)majorJoint call for proposals on unconventional information processing technologies targeting computing with light, magnetic quantum bits, hybrid quantum-AI systems, neuromorphic architectures, and supercomputing.
- Responsible AI UK (RAi UK)majorCollaboration on £200,000 RAi Collaboration Grants program including cross-cultural research on bias-mitigating social robots (Swansea-Kyoto collaboration) for responsible AI deployment in public services.
- Swansea UniversitymajorCross-cultural collaboration on bias-mitigating social robots as part of RAi UK's £200,000 Collaboration Grants programme.
- TeraversemajorTechnology partnership for BuddhaBot AI chatbot development and Buddharoid robot monk, trained on Buddhist scriptures for spiritual guidance applications.
- XNOVAmajorCollaboration on AI-powered robot monk Buddharoid and BuddhaBot spiritual guidance systems using advanced language models.
- Asahi Kasei Microdevices CorporationcoreJoint development of 2µm-band infrared photonic crystal surface-emitting laser (PCSEL) technology for greenhouse gas detection, non-invasive medical sensing, and high-performance LiDAR applications. Research results presented at Japan Society of Applied Physics Spring Meeting March 2026.
- Gladstone InstitutesmajorJoint development of MaxToki AI model for predicting cellular aging trajectories, trained on nearly 1 trillion gene tokens from 197 million single-cell transcriptomes.
- UCSF (University of California, San Francisco)majorCollaboration on MaxToki AI model development for cellular aging prediction research.
- UC BerkeleymajorPartnership on MaxToki AI model for predicting cellular aging trajectories across human lifespan.
- NVIDIAmajorTechnical collaboration on MaxToki AI model development, providing GPU computing infrastructure for training the transformer-based model.
- Goethe University FrankfurtmajorInternational collaboration on MaxToki AI model for cellular aging prediction research.
- Link and Motivation Inc.minorJoint research with Kyoto Original Co., Ltd. on 'International Human Resource Management in Southeast Asia' to analyze global talent management among Japanese and non-Japanese firms.
- Mitsubishi Heavy IndustriescoreEstablishment of MHI Innovative Combustion Dynamics Laboratory (April 1, 2026 - March 2031) to develop gas turbine combined cycle power plants exceeding 70% efficiency and carbon-neutral combustion technologies including hydrogen fuels. Five-year research collaboration focusing on advanced combustion control and numerical simulations.
- Mitsubishi Heavy IndustriescoreJoint industry-academia course for developing combustion technology achieving >70% efficiency and carbon-neutral combustion including hydrogen research. Five-year program through March 2031 with talent development focus.
- Sharp CorporationmajorCollaboration on long-range video monitoring technology using AI for 5-10km distance analysis, combining Kyoto University's VHF band wireless transmission with Sharp's Dynamic Video Monitoring Technology. Part of Japan-US-Australia R&D project commissioned by NICT.
- Waseda UniversitymajorCollaboration on long-range AI video monitoring technology as part of Japan-US-Australia R&D project.
- Southern University of Science and TechnologyminorJoint development of self-healing CMOS imager prototype for space radiation environments, capable of detecting and repairing radiation-damaged pixels through targeted heating.
- IEEEminorResearch presented at IEEE International Solid State Circuits Conference on self-healing electronics for space radiation environments.
- LivingPhoenix (Chengdu, China)minorTechnology transformation partnership in Chengdu where Kyoto University Engineering team developed triple-helix biomimetic collagen rated as 'International Leading-Edge'. Company has international patent protections.
- Genequest Inc.minorResearch collaboration using causal AI to analyze links between genetics, lifestyle, and health. Study analyzed genetic data and questionnaires from approximately 4,000 individuals.
- Fujitsu LimitedminorCausal AI research partnership for analyzing genetics, lifestyle, and health connections for personalized health measures.
- NUS Enterprise (National University of Singapore)majorPartnership under BLOCK71 network for international startup ecosystem development and deep tech collaboration alongside Stanford University, Toyoda Gosei, and Microsoft.
- 700-million-year-old evolutionary ancestor research (across species)minorResearch tracing FOS gene evolution across species from single-celled organisms to human blood cell development, published in PNAS.
- Sumitomo PharmacoreIndustry partnership for iPS cell-derived Parkinson's disease treatment (Amchepry), receiving conditional regulatory approval from Japanese government. Treatment transplanting stem cells into patients' brains with results published in Nature.
- Medical startup CuoripsmajorPartnership on ReHeart heart muscle sheets for regenerative heart treatment, receiving regulatory approval alongside iPS cell treatments.
- National Institute of Information and Communications Technology (NICT)majorJapan-US-Australia R&D project commissioned by NICT for developing long-range AI video monitoring technology using VHF band wireless transmission.
- NASA (for LignoSat wooden satellite project)majorCollaboration on LignoSat wooden CubeSat deployment from ISS, testing wood as alternative to aluminum for satellite construction to reduce atmospheric pollution from reentry.
- JAXA (Japan Aerospace Exploration Agency)majorPartnership on LignoSat wooden satellite project with Sumitomo Forestry for testing wood durability in space environment.
- Sumitomo ForestrymajorCollaboration on LignoSat wooden satellite project, utilizing magnolia wood (honoki) for satellite construction to assess atmospheric pollution reduction.
- Patients and families (research participants)minorResearch event on ulcerative colitis aimed at understanding and curing the disease, fostering connections among patients, families, and researchers.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Kyoto University competitors and assessment
Company assessmentBroad incumbents
- University of Cambridge: Historic comprehensive research university with comparable multi-disciplinary depth, Nobel laureate pedigree, and biomedical/physics research strength. Comparable international partnership network and medical school.
- ETH Zurich: Europe's leading technical university with deep strength in photonics, AI, and applied engineering — overlapping Kyoto's Katsura Campus engineering and PCSEL laser research domains. Comparable industry partnership models.
- Stanford University: Global research powerhouse with comparable strengths in AI, biomedical engineering, and industry partnerships. Shares Kyoto's iPS-adjacent regenerative medicine and technology transfer orientation, with deeper Silicon Valley commercialization ties.
- Harvard University: Top biomedical research university with comparable medical school and regenerative medicine capabilities. Shares Kyoto's role as a global hub for life sciences research and clinical translation.
- California Institute of Technology: Premier science and engineering research institution with deep overlap in physics (atomic clock), space technology (LignoSat), and small-scale elite research model — though smaller in scale than Kyoto's comprehensive footprint.
- University of Oxford: Comprehensive research university with comparable academic freedom tradition, Nobel laureate depth, and multi-disciplinary research portfolio. Shared strength in biomedical sciences and humanities-based inquiry.
- Massachusetts Institute of Technology: Global leader in photonics, AI, quantum, and applied sciences — overlapping Kyoto's MaxToki AI, atomic clock, and PCSEL laser research domains. Comparable in deep-tech research output and industrial partnership intensity.
Regional players
- National University of Singapore: Asia's leading English-language research university with existing Kyoto partnership via NUS Enterprise BLOCK71 network. Direct competitor for top Asian STEM talent and industry partnerships in Southeast Asia.
Direct peers
- Tsinghua University: China's leading comprehensive research university, competing directly with Kyoto for Asian research talent, government funding, and global rankings. Strong in engineering and AI, with rapidly rising research output.
- University of Tokyo: Japan's flagship national research university and Kyoto's closest direct competitor for top Japanese talent, government research funding, and international rankings. Comparable in scale, comprehensive disciplinary coverage, and Nobel laureate pedigree.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Kyoto University social profiles
Digital presenceKyoto University financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kyoto University leadership team
Management profileNumber of profiles
Profiles4 records
Kyoto University funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kyoto University M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kyoto University
What does Kyoto University do?
Kyoto University is a National University Corporation that delivers higher education (undergraduate through doctoral), advanced research outputs, and clinical care. Core offerings include degree programs across multiple faculties, industry-sponsored joint research, technology licensing, regenerative medicine products derived from iPS cell technology, AI models (MaxToki, BuddhaBot), photonic devices (PCSEL laser), hospital medical services, and continuing/public education.
Is Kyoto University a public or private company?
Kyoto University is a public company. It is classified as state government owned and is currently operating.
When was Kyoto University founded?
Kyoto University was founded in 1897. It employs 1,001 to 5,000 people.
Where is Kyoto University based?
Kyoto University is headquartered in Kyoto, Japan, in the Asia region.
Who are Kyoto University's main competitors?
Broad incumbents on record are University of Cambridge, ETH Zurich, Stanford University, Harvard University, California Institute of Technology, University of Oxford and Massachusetts Institute of Technology. National University of Singapore is listed as a regional player. Direct peers are Tsinghua University and University of Tokyo.
Does Kyoto University have an API?
No public API is recorded for Kyoto University.